<DOC>
	<DOCNO>NCT02980133</DOCNO>
	<brief_summary>This study evaluate safety efficacy Fluticasone Propionate Fluticasone propionate Salmeterol pediatric patient document history persistent asthma .</brief_summary>
	<brief_title>Study Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>The patient diagnosis asthma define NIH The patient persistent asthma FEV1 ≥50 % ≤90 % value predict age , height , sex , race screen visit ( SV ) . The patient 's persistent asthma stable currently treat stable asthma therapy least 30 day SV . The patient ( assistance parents/legal guardians/caregivers , need ) able perform technically acceptable lung function assessment handheld device The patient ( assistance parents/legal guardians/caregivers , need ) able use MDI device MDPI device . All patient must able replace current SABA albuterol/salbutamol HFA MDI inhalation aerosol SV use need duration study Additional criterion apply , please contact investigator information The patient history lifethreatening asthma exacerbation define protocol asthma episode require intubation and/or associate hypercapnia , respiratory arrest , hypoxic seizure . The patient pregnant lactating plan become pregnant study period within 30 day patient 's last studyrelated visit . The patient know hypersensitivity corticosteroid , salmeterol , excipients IMP rescue medication formulation ( ie , lactose ) . The patient treat know strong cytochrome P450 ( CYP ) 3A4 inhibitor ( eg , ketoconazole , ritonavir , clarithromycin ) within 30 day SV plan treat strong CYP3A4 inhibitor study . The patient currently smoke smoke history . The patient must use tobacco product within past year ( eg , cigarette , cigar , chew tobacco , pipe tobacco ) . The patient asthma exacerbation require systemic corticosteroid within 30 day SV hospitalization asthma within 2 month SV . The patient use immunosuppressive medication within 30 day screen visit . The patient untreated oral candidiasis SV . Patients clinical visual evidence oral candidiasis agree receive treatment comply appropriate medical monitoring may enter runin period . The patient history positive test human immunodeficiency virus , active hepatitis B virus , hepatitis C infection . The patient immediate relative employee clinical investigational center . A member patient 's household participate study time Vulnerable patient ( ie , people keep detention ) exclude participation . Additional criterion apply , please contact investigator information</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>